XIIIth International Cancer Congress in Seattle Drawing Record Numbers Or Top Scientific Program
In Brief: NCAB Lacked Courage On Some Special Actions, Amos Says; Pick Reviewers On Ability Only, Scientist Asks
Tim Lee Carter Says He Wants Government To Abide By spirit Of 1971 Cancer Act
Johnson, Katterhagen Applaud CCOP RFA But With It Had Money For More Cancer Control
New Clinical Trials Monitoring Program To Site Visit PIs Every Three Years
Last Issue Until Aug. 20
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial









